Biotech & Medtech
Biotech & Medtech news — Friday 16 October 2026
25 stories from 4 sources, every one in English. Each links to its publisher.
-
Why Epic Is Launching a Prescription Price Comparison Tool
MedCity News
Epic will launch a tool in summer 2027 to help patients compare prescription cash prices and insurance costs across pharmacies. The post Why Epic Is Launching a Prescription Price Comparison Tool appeared first on MedCity News .
-
City Therapeutics’ Upsized IPO Raises $200M to Bring RNAi Drugs Beyond the Liver
MedCity News
City Therapeutics’ lead RNA interference therapy could become an alternative to blockbuster-selling anticoagulants. The company’s technology for designing RNAi drugs and delivering them to tissues throughout the body has already led to…
-
Iambic CEO on taking an AI drug company public
BioPharma Dive
Fresh off a $150 million IPO, Tom Miller spoke to BioPharma Dive about the roadshow process and how he sees AI’s role in drug development evolving.
-
Hospitals’ next lucrative bet — longevity clinics
STAT News
Longevity medicine is now estimated to be a multitrillion dollar industry. But what are people paying for, and does it work? On this week’s episode of “The Readout LOUD,” STAT’s biotech podcast, we bring on STAT reporter Sarah Todd to…
-
STAT+: Up and down the ladder: The latest comings and goings
STAT News
Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s right. Send us your changes, and we’ll find a home for them . Don’t be shy…
-
The Impending End of Cross-Subsidization
MedCity News
There is no single solution to the cross-subsidization problem. But here are some strategic actions that can make a health system’s economics more sustainable. The post The Impending End of Cross-Subsidization appeared first on MedCity…
-
STAT+: Pharmalittle: We’re reading about an HHS peptide push, Trump’s pharma stock holdings, and more
STAT News
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is, so far, rather modest. We plan to catch up on our reading…
-
STAT+: RevMed’s pancreatic cancer drug nears European approval
STAT News
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. We’re leaving room for popcorn and intrigue tonight: The new A24 documentary, “You Can See Everything,” hits…
-
This week in charts: Moderna’s massive stock run
BioPharma Dive
The latest installment in BioPharma Dive’s data visualization-focused series includes a look at Moderna’s meteoric rise in 2026 and a sudden deal surge from Roche.
-
How AI Is Connecting MedTech’s Data Without Compromising Compliance
MedCity News
The connected, agent-ready enterprise is the model that wins, where compliance and intelligence operate together. The post How AI Is Connecting MedTech’s Data Without Compromising Compliance appeared first on MedCity News .
-
What to read before you go see that new documentary on Elizabeth Holmes
STAT News
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here . Happy Friday from sunny San Diego. This is Jonathan Wosen, West Coast biotech & life sciences reporter. We’ve got a strong…
-
Next-gen RNAi drugmaker City prices $200M IPO
BioPharma Dive
The offering will support a trio of medicines in or nearing clinical testing, as well as earlier research into RNAi treatments that get into tissues outside the liver.
-
Biogen-backed Estuary nabs $93M for kidney disease gene therapy
BioPharma Dive
The Series A round, which was led by RA Capital, will help fund the development of two genetic medicines designed to treat an inherited kidney disorder known as "ADPKD."
-
STAT+: Coerced sex or a jealous ex? Jury weighs dueling accounts of star scientist David Sabatini’s downfall
STAT News
Was world-renowned molecular biologist David Sabatini a manipulative mentor who coerced a younger colleague into sex and cultivated a hostile work culture at his research lab in Cambridge? Or was he the victim of a spurned former lover and…
-
Opinion: I thought I knew why patients stopped taking their medicine. I was wrong
STAT News
During my years as a clinical pharmacist, I thought I understood why patients stopped taking long-term medications — one of the biggest challenges in medicine. They forgot to take them, became frustrated with side effects, or didn’t fully…
-
STAT+: In DOGE’s aftermath, federal health workers bristle at new performance reviews
STAT News
WASHINGTON — Changes to the annual performance review process are the latest flashpoint in tensions between federal workers across the Department of Health and Human Services and the Trump administration, federal employees told STAT. Staff…
-
Opinion: Is Milton Friedman to blame for America’s health care woes?
STAT News
Welcome to Friendly Argument, a new STAT First Opinion series in which two experts who disagree but respect each other’s point of view engage in a debate about medicine and health policy. In this installment, John E. McDonough , author of…
-
Brain-to-Language Decoding: Tasks, Signals, Methods, Evaluation, Practical Use and Beyond
arXiv cs.NE (Neural／Bio)
arXiv:2609.27650v3 Announce Type: replace-cross Abstract: Brain-to-language decoding translates neural activity associated with language production, internal speech and perception into linguistic or expressive outputs. It offers a route to…
-
Approaching Backpropagation Accuracy with Weight Perturbation on MNIST
arXiv cs.NE (Neural／Bio)
arXiv:2610.21665v1 Announce Type: cross Abstract: Weight perturbation (WP) estimates learning directions from random parameter perturbations and a scalar change in loss, without backpropagating derivatives. We examine how batch size…
-
A restart rule for genetic algorithms based on Schnabel census
arXiv cs.NE (Neural／Bio)
arXiv:2610.22211v1 Announce Type: new Abstract: A new adaptive restart rule for Genetic Algorithms (GAs) is considered. The rule is based on the Schnabel Census method, originally developed for statistical estimation of a size of animal…
-
Beyond the Hamming Cliff: Compact Spatial Encodings Preserving Semantic Distance in Spiking Neural Networks
arXiv cs.NE (Neural／Bio)
arXiv:2610.22083v1 Announce Type: new Abstract: By pre-processing input signals with Gray, Thermometer, Johnson and hybrid encodings before passing them to spiking neural networks running on SpiNNaker hardware, Davies et al.(2025) address…
-
PotentialEP: Backprop-Free Training of CIFAR-Scale Generative Models via Equilibrium Propagation
arXiv cs.NE (Neural／Bio)
arXiv:2610.14409v2 Announce Type: replace-cross Abstract: Generating an image with a diffusion or flow-matching model typically involves integrating a velocity field for hundreds of sequential steps. That computation suits a GPU poorly and…
-
Attention over noisy examples: generalization and memorization in the exponential Hopfield network
arXiv cs.NE (Neural／Bio)
arXiv:2610.22191v1 Announce Type: cross Abstract: In Hebbian learning from examples a Hopfield network of $N$ neurons is not supplied with the $K$ archetypes it has to retrieve but with $M$ blurred examples of each, of quality $r$, and…
-
First Mathematical Runtime Analyses of Evolutionary Multitask Multi-Objective Optimization
arXiv cs.NE (Neural／Bio)
arXiv:2610.21311v1 Announce Type: new Abstract: To facilitate the solving of complex problems, evolutionary multitask optimization is regarded as a promising technique due to its capacity for cross-task knowledge transfer. In contrast to…
-
T-GADE: Thermodynamical Generative-AI-Driven Evolution of LLM Artifacts
arXiv cs.NE (Neural／Bio)
arXiv:2609.12286v2 Announce Type: replace-cross Abstract: Introducing large language models (LLMs) into evolutionary computation enables semantic generation of candidates, but the classical problem of maintaining population diversity…